Correcting for targeted and control agent signal differences in paired-agent molecular imaging of cancer cell-surface receptors
暂无分享,去创建一个
[1] Brian W Pogue,et al. Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision , 2017, Journal of biomedical optics.
[2] H. Dvorak,et al. Vascular permeability, vascular hyperpermeability and angiogenesis , 2008, Angiogenesis.
[3] H. Dvorak,et al. Why are tumour blood vessels abnormal and why is it important to know? , 2009, British Journal of Cancer.
[4] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] Brian W. Pogue,et al. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions , 2016, Molecular Imaging and Biology.
[6] Tayyaba Hasan,et al. Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas. , 2010, Academic radiology.
[7] R. Coleman,et al. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis. , 1984, Anticancer research.
[8] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[9] Y. Assaraf,et al. The folate receptor as a rational therapeutic target for personalized cancer treatment. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[10] M F Kijewski,et al. Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] A. Ullrich,et al. Kinetics of binding, endocytosis, and recycling of EGF receptor mutants , 1992, The Journal of cell biology.
[12] Jeih-San Liow,et al. Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] R. Jain. Delivery of molecular and cellular medicine to solid tumors. , 2001, Advanced drug delivery reviews.
[14] T. Cloughesy,et al. Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma , 2015, Nature Reviews Cancer.
[15] T. Hasan,et al. Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors , 2012, Physics in medicine and biology.
[16] Vasilis Ntziachristos,et al. Accuracy of fluorescent tomography in the presence of heterogeneities:study of the normalized born ratio , 2005, IEEE Transactions on Medical Imaging.
[17] Mamta Khurana,et al. Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements. , 2010, Journal of biomedical optics.
[18] Jason R. Gunn,et al. In Vivo Quantification of Tumor Receptor Binding Potential with Dual-Reporter Molecular Imaging , 2012, Molecular Imaging and Biology.
[19] Brian W Pogue,et al. Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging modules. , 2016, Biomedical optics express.
[20] Sylvain Gioux,et al. qF-SSOP: real-time optical property corrected fluorescence imaging. , 2017, Biomedical optics express.
[21] Adam K Glaser,et al. Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy. , 2017, Cancer research.
[22] Tayyaba Hasan,et al. Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. , 2014, Cancer research.
[23] K. Tichauer,et al. Generalized paired-agent kinetic model for in vivo quantification of cancer cell-surface receptors under receptor saturation conditions , 2017, Physics in medicine and biology.
[24] S. Svanberg,et al. Medical diagnostic system based on simultaneous multispectral fluorescence imaging. , 1994, Applied optics.
[25] Brian W. Pogue,et al. High Vascular Delivery of EGF, but Low Receptor Binding Rate Is Observed in AsPC-1 Tumors as Compared to Normal Pancreas , 2011, Molecular Imaging and Biology.
[26] B. Pogue,et al. Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential. , 2014, Biomedical optics express.
[27] Eben L. Rosenthal,et al. Beyond the margins: real-time detection of cancer using targeted fluorophores , 2017, Nature Reviews Clinical Oncology.
[28] Jason S. Lewis,et al. Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis. , 2017, PET clinics.
[29] Keith Paulsen,et al. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use , 2017, Molecular Imaging and Biology.
[30] R. Weissleder,et al. Imaging in the era of molecular oncology , 2008, Nature.
[31] R. Jain,et al. Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[32] Sophie J Deharvengt,et al. Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo , 2013, Proceedings of the National Academy of Sciences.
[33] T. Hasan,et al. Accounting for pharmacokinetic differences in dual-tracer receptor density imaging , 2014, Physics in medicine and biology.
[34] Walter H Backes,et al. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. , 2005, Radiology.
[35] T. Cloughesy,et al. Harnessing Preclinical Molecular Imaging to Inform Advances in Personalized Cancer Medicine , 2017, The Journal of Nuclear Medicine.
[36] Stephen B. Tuttle,et al. Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue. , 2008, The Review of scientific instruments.
[37] Jonathan T. C. Liu,et al. Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging , 2015, Physics in medicine and biology.
[38] Yasuyoshi Watanabe,et al. [Molecular imaging for drug development]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.
[39] Tayyaba Hasan,et al. Comparison of Kinetic Models for Dual-Tracer Receptor Concentration Imaging in Tumors. , 2014, Austin journal of biomedical engineering.
[40] Michael S Patterson,et al. Quantification of fluorophore concentration in tissue-simulating media by fluorescence measurements with a single optical fiber. , 2003, Applied optics.
[41] Linton T. Evans,et al. Simultaneous In Vivo Fluorescent Markers for Perfusion, Protoporphyrin Metabolism, and EGFR Expression for Optically Guided Identification of Orthotopic Glioma , 2016, Clinical Cancer Research.
[42] I. Lax,et al. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. , 1993, Biochemistry.